Biomarkers & Hypersensitivity Pneumonitis Progression | Clinical Trials | National Jewish Health

;

Trial Objectives

Image-3269-(1).jpg Researchers are studying the blood of hypersensitivity pneumonitis (HP) patients to find out if biomarkers found can predict the progression of the disease. Researchers are particularly interested in understanding if the biomarkers in blood can predict the speed of disease progression.

Who Can Participate

Adults 18 years of age and older.

Age: 18-80 Gender Any

Estimated Time Commitment

Not Specified

Payment & Reimbursement

Payment Not Provided

Travel Reimbursement Not Available

Trial Contact

For more information, contact:

Elizabeth Del Real
303.398.1172

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

National Institutes of Health

Co-Investigators

Rebecca C. Keith, MD
Michael P. Mohning, MD
Joshua J. Solomon, MD
Zulma X. Yunt, MD

Request more Information

By completing this form, you agree to learn more about this study and see if you qualify.

First Name

Last Name

Email Address

Phone

I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health

Yes

No